{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:27:13Z","timestamp":1790868433184,"version":"4.1.0"},"reference-count":53,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,3,15]],"date-time":"2009-03-15T00:00:00Z","timestamp":1237075200000},"content-version":"vor","delay-in-days":42,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:p><jats:bold><jats:sc>summary<\/jats:sc><\/jats:bold> American Trypanosomiasis, or Chagas\u2019 disease, is a parasitic infection caused by the protozoan <jats:italic>Trypanosoma cruzi<\/jats:italic>. It is endemic in a large area of the American continent, extending from Mexico to Argentina. Imported Chagas\u2019 disease is now appearing as a new threat to non\u2010endemic countries, mostly because of a steady increase of foreign residents from Latin America. Chagas\u2019 disease becomes chronic in the vast majority of infected individuals. This finding gives rise to problems for blood transfusion services. In non\u2010endemic countries, transfusion is the most likely infection route. Strategies to reduce transmission by transfusion include blood donor selection and deferral, blood donation testing, leukoreduction, filters and pathogen inactivation systems. Policies in endemic and non\u2010endemic areas are quite different: in endemic countries, universal screening of blood donations for <jats:italic>T.\u2003cruzi <\/jats:italic>antibody detection is mandatory. However, in non\u2010endemic countries, there are two different approaches: one is the deferral of people at risk of Chagas\u2019 disease and the second approach is to accept the blood donation if specific laboratory assay results are negative. This second approach is being introduced in countries where there is a substantial Latin American population, such as United States, Spain and France. The assays used for the detection of <jats:italic>T.\u2003cruzi <\/jats:italic>are mostly immunologic, made with <jats:italic>T.\u2003cruzi <\/jats:italic>antigen homogenates or with recombinant antigens. Complementary assays, such as indirect immunofluorescence (IIF) or immunoblot, can help ascertain antibody specificity.<\/jats:p>","DOI":"10.1111\/j.1365-3148.2009.00915.x","type":"journal-article","created":{"date-parts":[[2009,3,16]],"date-time":"2009-03-16T02:00:49Z","timestamp":1237168849000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Chagas\u2019 disease: lessons from routine donation testing"],"prefix":"10.1111","volume":"19","author":[{"given":"E.","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,15]]},"reference":[{"key":"e_1_2_16_2_1","article-title":"Tracing of one year of Chagas screening at the Centro de Transfusion de Galicia (C.T.G.) concerning a positive blood donor (abstract)","volume":"93","author":"Abalo M.","year":"2007","journal-title":"Vox Sanguinis"},{"key":"e_1_2_16_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33193142312.x"},{"key":"e_1_2_16_4_1","first-page":"36","article-title":"Chagas\u2019 disease screening in the French blood donor population. Screening assays and donor selection","volume":"9","author":"Assal A.","year":"2007","journal-title":"Enfermedades Emergentes"},{"key":"e_1_2_16_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14694-6"},{"key":"e_1_2_16_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2007.07.002"},{"key":"e_1_2_16_7_1","first-page":"48","article-title":"Transfusi\u00f3n sangu\u00ednea y enfermedad de Chagas","volume":"8","author":"Castro E","year":"2006","journal-title":"Enfermedades Emergentes"},{"key":"e_1_2_16_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01133.x"},{"issue":"1","key":"e_1_2_16_9_1","article-title":"The effectiveness of UVC pathogen inactivation system on reducing the Trypanosoma cruzi and Leishmania Infantum burden in platelets (abstract)","volume":"95","author":"Castro E.","year":"2008","journal-title":"Vox Sanguinis"},{"key":"e_1_2_16_10_1","first-page":"210","article-title":"Chagas disease after organ transplantation \u2013 United Sates","volume":"51","author":"CDC","year":"2001","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"e_1_2_16_11_1","article-title":"Chagas disease after organ transplantation \u2013 Los Angeles, California","volume":"55","author":"CDC","year":"2006","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"e_1_2_16_12_1","first-page":"141","article-title":"Blood donor screening for Chagas\u2019 disease United States, 2006\u20102007","volume":"56","author":"CDC","year":"2007","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"e_1_2_16_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00965.x"},{"key":"e_1_2_16_14_1","first-page":"48","article-title":"Transfusion\u2010associated Chagas\u2019 disease in Texas: report of a case","volume":"89","author":"Cimo P.L.","year":"1993","journal-title":"Texas Medicine"},{"key":"e_1_2_16_15_1","article-title":"10\u2010month experience screening USA blood donors for Trypanosoma cruzi: yield, risk factors, and cost effectiveness","volume":"95","author":"Custer S.","year":"2008","journal-title":"Vox Sanguinis"},{"key":"e_1_2_16_16_1","doi-asserted-by":"publisher","DOI":"10.1157\/13111835"},{"key":"e_1_2_16_17_1","doi-asserted-by":"publisher","DOI":"10.1086\/527448"},{"key":"e_1_2_16_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705551"},{"key":"e_1_2_16_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00340.x"},{"key":"e_1_2_16_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2006.01.010"},{"key":"e_1_2_16_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2008.05.003"},{"key":"e_1_2_16_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00840.x"},{"key":"e_1_2_16_23_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-10-849"},{"key":"e_1_2_16_24_1","volume-title":"Spain census data (database on the internet)","author":"Instituto Nacional de Estad\u00edstica","year":"2008"},{"key":"e_1_2_16_25_1","article-title":"Investigation of the second case of transfusion transmitted Chagas disease in Canada (abstract)","volume":"96","author":"Lane D.J.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_16_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39399219290.x"},{"key":"e_1_2_16_27_1","doi-asserted-by":"publisher","DOI":"10.1086\/590159"},{"key":"e_1_2_16_28_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00077.x"},{"key":"e_1_2_16_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910143411615"},{"key":"e_1_2_16_30_1","doi-asserted-by":"publisher","DOI":"10.1086\/516534"},{"key":"e_1_2_16_31_1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/014107688107400612","article-title":"Carlos Chagas and the discovery of Chagas\u2019 disease (American trypanosomiasis)","volume":"74","author":"Lewinsohn R","year":"1981","journal-title":"Journal of the Royal Society Of Medicine"},{"key":"e_1_2_16_32_1","first-page":"31288","volume-title":"Real Decreto 1088\/2005 por el que se establecen los requisitos t\u00e9cnicos y condiciones m\u00ednimas de la hemodonaci\u00f3n y de los centros y servicios de transfusi\u00f3n del 20 de septiembre de 2005","author":"Ministry of Health","year":"2005"},{"key":"e_1_2_16_33_1","doi-asserted-by":"publisher","DOI":"10.1179\/136485906X112248"},{"key":"e_1_2_16_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.35996029154.x"},{"key":"e_1_2_16_35_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-111-10-851"},{"key":"e_1_2_16_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01602.x"},{"key":"e_1_2_16_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2007.03.002"},{"key":"e_1_2_16_38_1","first-page":"36","article-title":"Primeiras verificacoes de transmissao acidental da mol\u00e9stia de Chagas ao homem por transfusao de sangue","volume":"40","author":"Pedreira de Freitas J.L.","year":"1952","journal-title":"Revista Paulista de Medicina"},{"key":"e_1_2_16_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2005.04214.x"},{"key":"e_1_2_16_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(01)00065-2"},{"key":"e_1_2_16_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2004.12.001"},{"key":"e_1_2_16_42_1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/JCM.38.2.851-854.2000","article-title":"Serological confirmation of Chagas\u2019 disease by a recombinant and peptide antigen line immunoassay: INNO\u2010LIA Chagas","volume":"38","author":"Saez\u2010Alquezar A.","year":"2000","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_16_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1991.31691306255.x"},{"key":"e_1_2_16_44_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762007005000093"},{"key":"e_1_2_16_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2824.2007.00052.x"},{"key":"e_1_2_16_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4922(01)01897-9"},{"key":"e_1_2_16_47_1","article-title":"An immunoblot assay using recombinant antigens to confirm antibodies to Trypanosoma cruzi","volume":"95","author":"Shah D.O.","year":"2008","journal-title":"Vox Sanguinis"},{"key":"e_1_2_16_48_1","article-title":"US blood donor screening for Trypanosoma cruzi: clinical studies and first year experience","volume":"95","author":"Stramer L.","year":"2008","journal-title":"Vox Sanguinis"},{"key":"e_1_2_16_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.34.9.2143-2147.1996"},{"key":"e_1_2_16_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.2.475-479.2003"},{"key":"e_1_2_16_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2824.2006.00023.x"},{"key":"e_1_2_16_52_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.35395184278.x"},{"key":"e_1_2_16_53_1","first-page":"1","article-title":"Report of WHO Expert Committee","volume":"905","author":"World Health Organization, Control of Chagas Disease","year":"2002","journal-title":"World Health Organization Technical Report Series"},{"key":"e_1_2_16_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.01147.x"}],"container-title":["Transfusion Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3148.2009.00915.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3148.2009.00915.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T23:54:35Z","timestamp":1696895675000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3148.2009.00915.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1365-3148.2009.00915.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3148.2009.00915.x","archive":["Portico"],"relation":{},"ISSN":["0958-7578","1365-3148"],"issn-type":[{"value":"0958-7578","type":"print"},{"value":"1365-3148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"2009-03-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}